UPDATE : Wednesday, September 18, 2019
상단여백
Drugmakers cut entertainment expense due to anticorruption law by Park Gi-taek 2017-08-25 16:27
Novartis gets EU approval for breast cancer drug by Marian Chu 2017-08-25 11:12
Graminex opens Seoul office by Marian Chu 2017-08-25 10:08
Pharmaceutical sectors of major countries show mixed results by Nam Doo-hyun 2017-08-24 18:35
Quadrivalent influenza vaccines enter fierce sales competition by Nam Doo-hyun 2017-08-24 15:04
라인
JW Pharma revalidates diabetes safety of hyperlipidemia treatment by Marian Chu 2017-08-23 12:16
Triumeq aims to change HIV drug market with easy use by Nam Doo-hyun 2017-08-23 12:12
Daewoong releases improved influenza treatment by Marian Chu 2017-08-23 10:34
Dong-A ST, Rooyan Darou sign business alliance for biologics by Marian Chu 2017-08-22 16:07
2 immuno-oncology therapies receive insurance coverage by Kwak Sung-sun 2017-08-21 15:03
라인
Amgen’s extended trial for osteoporosis treatment brings good results by Marian Chu 2017-08-21 14:49
Boryung to improve antihypertensive drug by Marian Chu 2017-08-18 16:33
Samyang develops multiple myeloma tablets for elderly by Constance Williams 2017-08-18 12:02
Pfizer gets FDA nod for lymphoid leukemia drug by Constance Williams 2017-08-18 10:25
27 ‘innovative’ drugmakers spend ₩588 billion on R&D by Lee Hye-seon 2017-08-17 16:31
라인
Takeda Korea unveils drug for ulcerative colitis, Crohn’s disease by Constance Williams 2017-08-17 15:42
SillaJen, US National Cancer Institute to conduct trials for Pexa-Vec by Marian Chu 2017-08-17 15:11
BMS at crossroads with mixed Opdivo-Yervoy trial results by Marian Chu 2017-08-17 11:24
Pfizer criticized for steep price hikes in global markets by Marian Chu 2017-08-17 08:53
Amgen Korea releases high-cholesterol treatment by Constance Williams 2017-08-16 17:19
여백
여백
여백
Back to Top